We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-3.68%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$982M
AUM Growth
+$92.9M
Cap. Flow
+$134M
Cap. Flow %
13.65%
Top 10 Hldgs %
4.69%
Holding
1,940
New
653
Increased
414
Reduced
285
Closed
576

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$4.61M
2
DPZ icon
Domino's
DPZ
+$3.96M
3
BRKR icon
Bruker
BRKR
+$3.65M
4
TJX icon
TJX Companies
TJX
+$3.62M
5
SBUX icon
Starbucks
SBUX
+$3.58M

Sector Composition

Rank Sector Weight
1 Healthcare 17.3%
2 Industrials 16.2%
3 Technology 12.7%
4 Financials 11.7%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRRX
626
DELISTED
DURECT Corp
DRRX
$572K 0.06%
44,718
+5,244
+13% +$71.1K
JBGS
627
JBG SMITH
JBGS
$708M
$571K 0.06%
+19,276
New +$595K
ATEN icon
628
A10 Networks
ATEN
$1.95B
$569K 0.06%
+42,188
New +$547K
BCLI
629
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$568K 0.06%
11,470
+7,454
+186% +$392K
EQT icon
630
EQT Corp
EQT
$32.3B
$566K 0.06%
+27,684
New +$536K
ONC
631
BeOne Medicines Ltd
ONC
$39.4B
$566K 0.06%
+1,560
New +$510K
GCMG icon
632
GCM Grosvenor
GCMG
$820M
$565K 0.06%
49,055
+20,254
+70% +$220K
PENG
633
Penguin Solutions Inc
PENG
$2.99B
$565K 0.06%
25,406
-7,548
-23% -$181K
AGRX
634
DELISTED
Agile Therapeutics
AGRX
$564K 0.06%
293
+107
+58% +$242K
AVDL
635
DELISTED
Avadel Pharmaceuticals
AVDL
$560K 0.06%
57,148
+4,215
+8% +$33.2K
BUSE icon
636
First Busey Corp
BUSE
$2.56B
$560K 0.06%
22,739
-11,738
-34% -$277K
TISI icon
637
Team
TISI
$77.7M
$560K 0.06%
18,605
+9,344
+101% +$450K
B
638
DELISTED
Barnes Group Inc.
B
$558K 0.06%
+13,380
New +$637K
VGR
639
DELISTED
Vector Group Ltd.
VGR
$553K 0.06%
+61,205
New +$597K
JBLU icon
640
JetBlue
JBLU
$2.29B
$552K 0.06%
+36,080
New +$554K
CPT icon
641
Camden Property Trust
CPT
$11.3B
$551K 0.06%
3,738
+598
+19% +$87.7K
MA icon
642
Mastercard
MA
$493B
$551K 0.06%
1,585
+105
+7% +$38.2K
ATCO
643
DELISTED
Atlas Corp.
ATCO
$551K 0.06%
36,287
-44,204
-55% -$632K
KIDS icon
644
OrthoPediatrics
KIDS
$595M
$549K 0.06%
8,381
-14,706
-64% -$955K
COST icon
645
Costco
COST
$420B
$548K 0.06%
1,219
-1,408
-54% -$619K
ENS icon
646
EnerSys
ENS
$6.99B
$547K 0.06%
7,343
+4,900
+201% +$435K
CAAP icon
647
Corporacion America
CAAP
$4.09B
$546K 0.06%
96,955
+11,204
+13% +$61.5K
SPYM
648
State Street SPDR Portfolio S&P 500 ETF
SPYM
$168B
$546K 0.06%
10,817
+1,333
+14% +$69.1K
NGNE icon
649
Neurogene
NGNE
$712M
$545K 0.06%
+3,771
New +$577K
AVXL icon
650
Anavex Life Sciences
AVXL
$310M
$544K 0.06%
30,301
+13,298
+78% +$265K

Similar funds

GSA Capital Partners's Q3 2021 Portfolio in Review

As of Q3 2021, GSA Capital Partners held 1,940 positions worth $982M, up 10% from $889M the previous quarter. Its ten largest holdings account for 4.7% of the portfolio.

GSA Capital Partners deployed $134M of net new capital in Q3 2021, opening 653 new positions and adding to 414 existing holdings. Its largest new stake was Openlane: 280,405 shares worth $4.6M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Amazon, an estimated $4.61M trimmed.

  • GSA Capital Partners's largest Q3 2021 buy was Openlane: 280,405 shares worth $4.6M.
  • GSA Capital Partners added most to BridgeBio Pharma in Q3 2021, an estimated $4.54M increase.
  • GSA Capital Partners's biggest Q3 2021 reduction was Amazon, cutting an estimated $4.61M.
  • GSA Capital Partners fully exited TJX Companies in Q3 2021, selling an estimated $3.62M.
  • GSA Capital Partners's ten largest holdings make up 4.7% of its $982M portfolio in Q3 2021.
  • GSA Capital Partners opened 653 new positions and closed 576 in Q3 2021.
  • GSA Capital Partners's portfolio value rose 10% quarter-over-quarter to $982M.

Based on GSA Capital Partners's 13F filing for Q3 2021, filed 12 Nov 2021.